Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 4, 2010, Pages 367-375

  Krenke, Rafał ^a   Korczyński, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adenosine deaminase; Interferon gamma; Tuberculosis; Tuberculous pleural effusion; Tuberculous pleuritis

Indexed keywords

ADENOSINE DEAMINASE; GAMMA INTERFERON; BIOLOGICAL MARKER;

DIAGNOSTIC ACCURACY; HUMAN; PLEURA BIOPSY; PLEURA FLUID; REVIEW; TUBERCULOUS PLEURISY; DIFFERENTIAL DIAGNOSIS; EXUDATE; NUCLEIC ACID AMPLIFICATION; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PLEURAL;

ADENOSINE DEAMINASE; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; EXUDATES AND TRANSUDATES; HUMANS; INTERFERON-GAMMA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PLEURAL; BIOMARKERS;

EID: 77953651125     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833a7154     Document Type: Review

References (71)

1. Salgueiro Rodríguez M, Gonzá lez Barcala J, Zamarró n Sanz C, et al. Tuberculosis in Santiago de Compostela from 1999 to 2002. An epidemiological study [in Spanish]. An Med Interna 2004; 21:215-222.
2. Seiscento M, Vargas FS, Rujula MJ, et al. Epidemiological aspects of pleural tuberculosis in the state of São Paulo, Brazil (1998-2005). J Bras Pneumol 2009; 35:548-554.
3. Peto HM, Pratt RH, Harrington TA, et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49:1350-1357.
4. Baumann MH, Nolan R, Petrini M, et al. Pleural tuberculosis in the United States: incidence and drug resistance. Chest 2007; 131:1125-1132.
5. Krenke R, Safianowska A, Papliń ska M, et al. Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculous pleurisy. J Physiol Pharmacol 2008; 59 (Suppl 6):349-360.
6. te Beek LA, van der Werf MJ, Richter C, Borgdorff MW. Extrapulmonary tuberculosis by nationality, The Netherlands, 1993-2001. Emerg Infect Dis 2006; 12:1375-1382.
7. Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL. Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 2008; 31:99-105.
8. Valdé s L, Pose A, San José E, Martínez Vázquez JM. Tuberculous pleural effusions. Eur J Intern Med 2003; 14:77-88.
9. Light RW. Pleural diseases. 5th ed. Philadelphia: Wolters Kluwer/Lippincott Wiliams & Wilkins; 2007. pp. 73-108, 211-224.
10. Pai M, Flores LL, Hubbard A, et al. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis 2004; 4:6.
11. Trajman A, Kaisermann C, Luiz RR, et al. Pleural fluid ADA, IgA-ELISA and PCR sensitivities for the diagnosis of pleural tuberculosis. Scand J Clin Lab Invest 2007; 67:877-884.
12. Porcel JM. Tuberculous pleural effusion. Lung 2009; 187:263-270.
13. Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131:880-889.
14. Diacon AH, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003; 22:589-591.
15. Valdé s L, Alvarez D, San José E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998; 158:2017-2021.
16. Lin MT, Wang JY, Yu CJ, et al. Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers. Respir Med 2009; 103:820-826.
17. Krenke R, Nasiłowski J, Korczyń ski P, et al. Incidence and etiology of eosinophilic pleural effusion. Eur Respir J 2009; 34:1111-1117.
18. Trajman A, Pai M, Dheda K, et al. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur Respir J 2008; 31:1098-1106.
19. Pé rez-Rodríguez E, Pé rez Walton IJ, Sanchez Hernández JJ, et al. ADA1/ ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid. Respir Med 1999; 93:816-821.
20. Gakis C. Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 1996; 9:632-633.
21. Pé rez-Rodriguez E, Jimé nez Castro D. The use of adenosine deaminase and adenosine deaminase isoenzymes in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med 2000; 6:259-266.
22. Poursharifi P, Saghiri R, Ebrahimi-Rad M, et al. Adenosine deaminase in patients with primary immunodeficiency syndromes: the analysis of serum ADA1 and ADA2 activities. Clin Biochem 2009; 42:1438-1443.
23. Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. BrMed J 1978; 2:1751-1752.
24. Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a metaanalysis. Int J Tuberc Lung Dis 2003; 7:777-786.
25. Goto M, Noguchi Y, Koyama H, et al. Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis. Ann Clin Biochem 2003; 40:374-381.
26. Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102:744-754.
27. Morisson P, Neves DD. Evaluation of adenosine deaminase in the diagnosis of pleural tuberculosis: a Brazilian meta-analysis. J Bras Pneumol 2008; 34:217-224.
28. Kü peli E, Karnak D, Elgün S, et al. Concurrent measurement of adenosine deaminase and dipeptidyl peptidase IV activity in the diagnosis of tuberculous pleural effusion. Diagn Microbiol Infect Dis 2009; 65:365-371.
29. Dheda K, Van-Zyl Smit RN, Sechi LA, et al. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS ONE 2009; 4:e4689.
30. Bandyopadhyay D, Gupta S, Banerjee S, et al. Adenosine deaminase estimation and multiplex polymerase chain reaction in diagnosis of extra-pulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 12:1203-1208.
31. Zarić B, Kuruc V, Milovancev A, et al. Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase? Lung 2008; 186:233-240.
32. Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM. Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS ONE 2008; 3:e2788.
33. Chung JH, Kim YS, Kim SI, et al. The diagnostic value of the adenosine deaminase activity in the pleural fluid of renal transplant patients with tuberculous pleural effusion. Yonsei Med J 2004; 45:661-664.
34. Valdés L, San José E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increasedADAin tuberculous pleurisy. EurRespir J 1996; 9:747-751.
35. Santotoribio JD, Leó n-Justel A, Delgado-Pecellín C, Guerrero JM. What are the biochemical parameters of pleural fluid that best identify parapneumonic effusions? Ann Clin Biochem 2009; 46:176-177.
36. Dikensoy O, Fakili F, Elbek O, Uysal N. High adenosine deaminase activity in the pleural effusion of a patient with Legionnaires' disease. Respirology 2008; 13:473-474.
37. Yoshino Y, Kitazawa T, Tatsuno K, et al. Cryptococcal pleuritis containing a high level of adenosine deaminase in a patient with AIDS: a case report. Respiration 2010; 79:153-156.
38. Zemlin AE, Burgess LJ, Carstens ME. The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions. Int J Tuberc Lung Dis 2009; 13:214-220.
39. Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest 1996; 109:414-419.
40. Dimakou K, Hillas G, Bakakos P. Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2009; 13:744-748.
41. Erer B, Yilmaz G, Yilmaz FM, Koklu S. Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-alpha therapy. Rheumatol Int 2009; 29:651-654.
42. Neves DD, Dias RM, Cunha AJ. Predictive model for the diagnosis of tuberculous pleural effusion. Braz J Infect Dis 2007; 11:83-88.
43. Sales RK, Vargas FS, Capelozzi VL, et al. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer. Respirology 2009; 14:1128-1133.
44. Porcel JM, Alemán C, Bielsa S, et al. A decision tree for differentiating tuberculous from malignant pleural effusions. Respir Med 2008; 102:1159-1164.
45. Ribera E, Ocañ a I, Martinez-Vazquez JM, et al. High level of interferon gamma in tuberculous pleural effusion. Chest 1988; 93:308-311.
46. Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect 2008; 10:995-1004.
47. Teixeira HC, Abramo C, Munk ME. Immunological diagnosis of tuberculosis: problems and strategies for success. J Bras Pneumol 2007; 33:323-334.
48. Chen X, Zhang M, Zhu X, et al. Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy. J Infect Dis 2009; 200:399-408.
49. Yokobori N, Schierloh P, Geffner L, et al. CD3 expression distinguishes two gammadeltaT cell receptor subsets with different phenotype and effector function in tuberculous pleurisy. Clin Exp Immunol 2009; 157:385-394.
50. Jiang J, Shi HZ, Liang QL, et al. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007; 131:1133-1141.
51. Dheda K, van Zyl-Smit RN, Sechi LA, et al. Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis. Eur Respir J 2009; 34:1118-1126.
52. Kim YK, Lee SY, Kwon SS, et al. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion. Lung 2001; 179:175-184.
53. Gerogianni I, Papala M, Tsopa P, et al. Could IFN-gamma predict the development of residual pleural thickening in tuberculous pleurisy? Monaldi Arch Chest Dis 2008; 69:18-23.
54. Okamoto M, Kawabe T, Iwasaki Y, et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 2005; 145:88-93.
55. Gao ZC, Tian RX. Clinical investigation on diagnostic value of interferongamma, interleukin-12 and adenosine deaminase isoenzyme for tuberculous pleurisy. Chin Med J 2005; 118:234-237.
56. Supriya P, Chandrasekaran P, Das SD. Diagnostic utility of interferon-gammainduced protein of 10 kDa (IP-10) in tuberculous pleurisy. Diagn Microbiol Infect Dis 2008; 62:186-192.
57. Valdé s L, San José E, Alvarez Dobaño JM, et al. Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions. Eur Respir J 2009; 33:816-820.
58. Djoba Siawaya JF, Chegou NN, van den Heuvel MM, et al. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 2009; 47:132-136.
59. Goletti D, Carrara S, Butera O, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNETstudy. PLoS ONE 2008; 3:e3417.
60. Lange C, Pai M, Drobniewski F, Migliori GB. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 2009; 33:1250-1253.
61. Hooper CE, Lee YC, Maskell NA. Interferon-gamma release assays for the diagnosis of TB pleural effusions: hype or real hope? Curr Opin Pulm Med 2009; 15:358-365.
62. Lee LN, Chou CH, Wang JY, et al. Enzyme-linked immunospot assay for interferon-gamma in the diagnosis of tuberculous pleurisy. Clin Microbiol Infect 2009; 15:173-179.
63. Liao CH, Chou CH, Lai CC, et al. Diagnostic performance of an enzymelinked immunospot assay for interferon-gamma in extrapulmonary tuberculosis varies between different sites of disease. J Infect 2009; 59:402-408.
64. Chegou NN, Walzl G, Bolliger CT, et al. Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis. Respiration 2008; 76:131-138.
65. Sharma SK, Banga A. Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis. J Clin Lab Anal 2005; 19:40-46.
66. Morimoto T, Takanashi S, Hasegawa Y, et al. Level of antibodies against mycobacterial glycolipid in the effusion for diagnosis of tuberculous pleural effusion. Respir Med 2006; 100:1775-1780.
67. Xue K, Xiong S, Xiong W. Clinical value of vascular endothelial growth factor combined with interferon-gamma in diagnosing malignant pleural effusion and tuberculous pleural effusion. J Huazhong Univ Sci Technolog Med Sci 2007; 27:495-497.
68. Daniil ZD, Zintzaras E, Kiropoulos T, et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J 2007; 30:957-964.
69. Ariga H, Kawabe Y, Nagai H, et al. Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells. Clin Infect Dis 2007; 45:1559-1567.
70. Feres MC, Martino MC, Maldijian S, et al. Laboratorial validation of an automated assay for the determination of adenosine deaminase activity in pleural fluid and cerebrospinal fluid. J Bras Pneumol 2008; 34:1033-1039.
71. Sakuraba M, Masuda K, Hebisawa A, et al. Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy. Ann Thorac Cardiovasc Surg 2009; 15:294-296.